These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9238614)

  • 1. Hyperhomocysteinaemia and end stage renal disease.
    Gupta A; Robinson K
    J Nephrol; 1997; 10(2):77-84. PubMed ID: 9238614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteinemia and vascular disease in end-stage renal disease.
    Dennis VW; Robinson K
    Kidney Int Suppl; 1996 Dec; 57():S11-7. PubMed ID: 8941916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine and renal disease.
    van Guldener C; Robinson K
    Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure.
    Bernasconi AR; Liste A; Del Pino N; Rosa Diez GJ; Heguilén RM
    Nephrology (Carlton); 2006 Apr; 11(2):137-41. PubMed ID: 16669976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin B6 metabolism and homocysteine in end-stage renal disease and chronic renal insufficiency.
    Lindner A; Bankson DD; Stehman-Breen C; Mahuren JD; Coburn SP
    Am J Kidney Dis; 2002 Jan; 39(1):134-45. PubMed ID: 11774112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
    Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
    Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine concentration changes after renal transplantation in children.
    Merouani A; Delvin EE; Genest J; Rozen R; Lambert M
    Pediatr Nephrol; 2002 Jul; 17(7):520-3. PubMed ID: 12172766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
    Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
    Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
    Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
    Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease.
    Blacher J; Demuth K; Guerin AP; Vadez C; Moatti N; Safar ME; London GM
    J Nephrol; 1999; 12(4):248-55. PubMed ID: 10493568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma homocysteine, a risk factor for premature vascular disease. Plasma levels in healthy persons; during pathologic conditions and drug therapy].
    Ueland PM; Refsum H
    Nord Med; 1989; 104(11):293-8. PubMed ID: 2813054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].
    Birn H
    Ugeskr Laeger; 2008 Mar; 170(11):933-7. PubMed ID: 18397619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis?
    Wasilewska A; Narkiewicz M; Rutkowski B; Łysiak-Szydłowska W
    Med Sci Monit; 2003 Mar; 9(3):CR147-51. PubMed ID: 12640345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients.
    Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid and Vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women.
    Dierkes J; Kroesen M; Pietrzik K
    Int J Vitam Nutr Res; 1998; 68(2):98-103. PubMed ID: 9565824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
    Bostom AG; Carpenter MA; Kusek JW; Hunsicker LG; Pfeffer MA; Levey AS; Jacques PF; McKenney J;
    Am Heart J; 2006 Sep; 152(3):448.e1-7. PubMed ID: 16923411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
    J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.
    Buccianti G; Baragetti I; Bamonti F; Furiani S; Dorighet V; Patrosso C
    J Nephrol; 2004; 17(3):405-10. PubMed ID: 15365961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.